Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.

Paul D Miller Nico Pannacciulli Rachel B Wagman Steven R Cummings

J Clin Endocrinol Metab

Colorado Center for Bone Research (P.D.M.), Lakewood, Colorado; Amgen Inc. (N.P., R.B.W.), Thousand Oaks, California; and San Francisco Coordinating Center (S.R.C.), CPMC Research Institute, San Francisco, California.

Published: September 2016

Download full-text PDF	Source
http://dx.doi.org/10.1210/jc.2016-2902	DOI Listing

Publication Analysis

Top Keywords

response letter

letter bone

bone turnover

turnover potential

potential determinant

determinant bone

bone mineral

mineral density

density increase

increase transition

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!